Device Trial Radar · NCT05082454
Post Market Clinical Follow-Up Study in Patients Treated With the On-X Ascending Aortic Prosthesis (AAP)
Last checked: Nov 20, 2026Latest source record: Feb 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
108
Actual
Start
Oct 20, 2021
Primary completion
Feb 6, 2024
Study completion Mar 31, 2029
Sponsor
- Lead sponsor
- JOTEC GmbHNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 19, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The ASCEND post-market clinical follow-up study is undertaken to evaluate safety and clinical performance of the On-X Ascending Aortic Prosthesis (AAP) used in surgical aortic valve replacement.
Conditions
- Aortic Valve Disease
Interventions
Open repairDevice
Open repair of the aortic heart valve and ascending thoracic aorta
Primary outcomes
What the sponsor says the trial is designed to measure.
- MortalityTime frame: at discharge to home or to rehabilitation
Locations
11 sites in 5 countries. Site status is shown where the registry gives one.
Geisinger Health System
Danville, Pennsylvania
Baylor College of Medicine
Houston, Texas
VCU Medical Center Main Hospital
Richmond, Virginia
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.